{"name":"Mundipharma Pharmaceuticals B.V.","slug":"mundipharma-pharmaceuticals-b-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oxycodone and naloxone","genericName":"Oxycodone and naloxone","slug":"oxycodone-and-naloxone","indication":"Moderate to severe pain","status":"phase_3"}]}],"pipeline":[{"name":"Oxycodone and naloxone","genericName":"Oxycodone and naloxone","slug":"oxycodone-and-naloxone","phase":"phase_3","mechanism":"Oxycodone is a mu-opioid receptor agonist, while naloxone is a mu-opioid receptor antagonist.","indications":["Moderate to severe pain","Opioid-induced respiratory depression"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNTWo1M0NMT1pzY1pDcjN1SGJrTmZmcE8xWTZGMVlEUTlSUDU4TzVFUUNUSmx1WjNSRGQ5VWh5VGhQRERlLU5qWnlRRF9GVzkydUpkMldUOTFfZ1B2S0dtLXpfSVZUQmhjeDRWVE01c2pPMjlKVjRRNzJtR21FV1RhbmZTTjkwV05JVDg2VnhZamFlZVM3T3hKOEFnQ2dLTXc?oc=5","date":"2024-09-17","type":"earnings","source":"Finance Uncovered","summary":"Revealed: How the Sackler family’s opioid empire continues to make hundreds of millions of dollars in profits around the world - Finance Uncovered","headline":"Revealed: How the Sackler family’s opioid empire continues to make hundreds of millions of dollars in profits around the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNMmpPT0t4bVdrQ0VjOEw2SHpFdkc3VDJsT1FRVDJrd1FpSlRnejBuRnZ5SjlVNlBPeEttYWJjRDI1dlhicTFtLTlBLWl2dTh2OG5Yc1oyZ2JGZzZjQXNraXNBT1I5R3JkV0luWW1Hb3BMcmVVbGo2QTBmVnpHMjUzemlPVmVKLXBBLUVwNHdGZGZTOWFwdHFOZ1dsbTFXczFaU21vb3VjcUZ1d2xhY2VZQVRVa1RjenZxX3R5T2l6bmdFb2Vk?oc=5","date":"2024-06-06","type":"pipeline","source":"The Pharmaceutical Journal","summary":"‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? - The Pharmaceutical Journal","headline":"‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWHlqOUU4QmZGc1liUDBmcGQ0YzkxZ0NHYkIzbzJqVUhERnlrcE02N3hNMWI2Yi03WU4wR1c2R3J2THp3TUoyNWNWeURqQkFwT2oxWWE4dXpsalJSR2lLWG1QQTdWNjBzc2RSc1BDMkxFZTRLQVd0NHNXdGtLS2JWSU11UzRjb21kUlQyck81YXN4WU5tdzBoemw0VQ?oc=5","date":"2023-08-16","type":"pipeline","source":"BioMelbourne Network","summary":"Starpharma to receive A$6.5M from Mundipharma and rights to VivaGel® BV - BioMelbourne Network","headline":"Starpharma to receive A$6.5M from Mundipharma and rights to VivaGel® BV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1GVDlVRzhJNzhOYzJyY2RrWVo2emo0Y1l2X2s5aXVTOTQ0ZjZsRUc5a1NkYXFMWmc0dTFjS0pra2R2TVlEX1JLdWcyUEV1eWtMNWZHSVRtY3pORENGVnRnU0NwQnphalc5SDBtaW9n0gFyQVVfeXFMTTIydkFKWXhuMVcydGk2YVZLdmhrY1VfQU5wZlVOWFZQWHFFVGxjNGpEanpjb3JCYzdiSXdycG01SzAzVEhfQ05KYWE5Z0F4Tk52WmEtX2dZLVBFMGhZSHE5NGYxOFNfOElXUGhfQ3BsOUtR?oc=5","date":"2023-01-06","type":"earnings","source":"koreabiomed.com","summary":"What will happen to Mundipharma Korea as its headquarters sell out foreign offshoots? - koreabiomed.com","headline":"What will happen to Mundipharma Korea as its headquarters sell out foreign offshoots?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8teWZ5TEdBdm14SmpxQ3pwYmUxM3A4R29ZRjNUOXJSeTdfT1pMNzdxLUozV3dscUwxMXNUU0J1T256bmVjQWdnSTRrV21COU0zTHBmSDVvVGhINFE4VjAtQ1hpTlR3WkZWRHpuS0xR0gFyQVVfeXFMTmQ0Z3FVT1Z4bGVDZi01R1VYeHhhaVJHTS1FTzRTdHBObVNkY0l0S3o4SHdaWDdudEFwUmpkNS1FSWhPYWVXdDhMYUxkaml4ZUpfMGNIWEF6TENNZGxKM29iWnBWR1hNMFZESVQ5STFvUS1R?oc=5","date":"2023-01-03","type":"pipeline","source":"koreabiomed.com","summary":"Are results of Mundipharma's 25-year business in Korea debt of ₩200 billion? - koreabiomed.com","headline":"Are results of Mundipharma's 25-year business in Korea debt of ₩200 billion?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE0xWWk0MXJvRXlad21LbWlhRDRRX3F1ei03clFpT3JocXJkV3hBSG0xVmViOHpUcnNnQU1kNnFaVGVtUHc5UFpCSWJxZDFIdmhtRVVJWDdoVkRTT0hBcU12QWQ0NzgzNm8?oc=5","date":"2015-12-09","type":"pipeline","source":"GIGAZINE","summary":"Meiji completed the manufacture and sale of \"Isodin\", and from April launched the \"Meiji-moigai drugs\" series - GIGAZINE","headline":"Meiji completed the manufacture and sale of \"Isodin\", and from April launched the \"Meiji-moigai drugs\" series","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}